00006-4109 GARDASIL - CanMED: NDC

Product NDC:

00006-4109

Brand Name:

GARDASIL

Generic Name:

Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant

Dosage Form Name:

INJECTION, SUSPENSION

Administration Route:

Intramuscular

Substances:

Name: HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN

Strength: 40.0

Unit: ug/.5mL

Name: HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN

Strength: 40.0

Unit: ug/.5mL

Name: HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN

Strength: 20.0

Unit: ug/.5mL

Name: HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN

Strength: 20.0

Unit: ug/.5mL

Packages:

Code: 00006-4109-01

Description:

Effective Date: June 8, 2006

Discontinued:

Code: 00006-4109-02

Description: 10 SYRINGE in 1 CARTON (0006-4109-02) / .5 mL in 1 SYRINGE (0006-4109-01)

Effective Date: June 8, 2006

Discontinued:

Code: 00006-4109-06

Description:

Effective Date: June 8, 2006

Discontinued: May 6, 2011

Code: 00006-4109-09

Description: 6 SYRINGE in 1 CARTON (0006-4109-09) / .5 mL in 1 SYRINGE (0006-4109-01)

Effective Date: June 8, 2006

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Protective Agent

Minor Class:

HPV Vaccine

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox

CanMED: NDC